Project Description
EMAI FDA GLP Contract Research Organization CRO needed for FDA GLP preclinical toxicology and Immunogenicity studies with primates where our products can
be evaluated by IV route, administrated daily during 12 weeks and 4 weeks of
recovery period.
We want evaluated comparatively two products with two level doses and a
control group. The number of animals per group would be 3
animals/sex/group. It would be evaluated Hematology/Biochemistry parameters.
Also, we want do toxicokinetics, immunogenicity and local tolerance
evaluations.
Project Information
Number:14-00516